A longitudinal evaluation of the effects of thyroxine therapy on bone mineral density

Journal of Clinical Densitometry

Volumn 1, Issue 2, 1998, Pages 173-177

  Ryan, P J ^a  

^a MEDWAY MARITIME HOSPITAL   (United Kingdom)

Author keywords

Carcinoma; Osteoporosis; Thyroid; Thyroxine

Indexed keywords

EID: 0011007307     PISSN: 10946950     EISSN: None     Source Type: Journal    
DOI: 10.1385/JCD:1:2:173     Document Type: Article

References (15)

1. Ross HN, Moses AC, Gundberg C, et al. 1987 Subclinical hyerthyroidism and reduced bone density as a possible result of prolonged suppression of the pitruitary-thyroid axis with 1-thyroxine. Am J Med 82: 1167-1170.
2. Adlin. EV, Maurer AH, Marks AD, Channick BJ. 1991 Bone mineral density in postrmenopausal women treated with L-thyroxine. Am J Med 90:360-366.
3. Kung AWC, Pun KK, 1991 Bone mineral density in premenopausal women receiving long term physiological doses of levothyroxine. JAMA 265:2688-2691.
4. Diamond T, Nery L, Hales I, 1990 A Therapeutic Dilemma: Suppressive doses of thyroxine significantly reduce bone mineral measurements in both premenopausal and postmenopausal women with thyroid carcinoma. J Clin Endocrinol Metab 72:1184-1188.
5. Diamond T, Vine J, Smart R, Butler P. 1994 Thyrotoxic bone disease in women: A potentially reversible disorder. Ann Int Med 120:8-11.
6. Krolner B, Jorgensen JV, Nielsen SP. 1983 Spinal bone mineral content in myxoedema and thyrotoxicosis. Effects of thyroid hormones and antithyroid treatment. Clin Endocrinol 18:439-446.
7. Krakauer J, Kleerekoper M. 1992 Borderline low serum thyrotrophin level is correlated with increased fasting urinary hydroxyproline excretion. Arch Int Med 152:360-364.
8. Grant DJ, McMurdo MET, Mole PA, Paterson CR, Davies RR. 1993 Suppressed TSH levels secondary to thyroxine replacement therapy are not associated with osteoporosis. Clin Endocrinol 39:529-533.
9. Franklyn JA, Betteridge J, Daykin J, et al. 1994 Long term thyroxine treatment and bone mineral density. The Lancet 340:9-13.
10. Florkowski CM, Brownlie BEW, Elliot JR, Ayling EM, Turner JG. 1993 Bone mineral density in patients receiving suppressive doses of thyroxine for thyroid carcinoma. NZ Med J 106:443-444.
11. Marcocci C, Golia F, Bruno-Bossio G, Vignali E, Pinchera A. 1994 Carefully monitored levothyroxine suppressive therapy is not associated with bone loss in pre menopausal women. J Clin Endo Metab 78:818-823.
12. Stall GM, Harris S, Sokoll L, Dawson-Hughes B. 1990 Accelerated bone loss in patients overtreated with L-thyroxine. Ann Int Med 113:265-269.
13. Fowler PBS, McIvor J, Sykes L, Macrae KD. 1996 The effect of long term thyroxine on bone mineral density and serum cholesterol. J Royal Coll Phys 30:527-532.
14. Muller CG, Bayley TA, Harrison JE, Tsang R. 1995 Possible limited bone loss with suppressive thyroxine therapy is unlikely to have clinical relevance. Thyroid 5:81-87.
15. Bauer DC, Nevitt MC, Ettinger B, K.Stone. 1997 Low thyrotrophin levels are not associated with bone loss in older women: a prospective study. J Clin Endocrinol and Metab 82:2931-2936.